Accuracy of fluorodeoxyglucose-positron emission tomography within the clinical practice of the American College of Surgeons Oncology Group Z4031 trial to diagnose clinical stage i non-small cell lung cancer

Annals of Thoracic Surgery

Volumn 97, Issue 4, 2014, Pages 1142-1148

  Grogan, Eric L ^a,b,c   Deppen, Stephen A ^b,c   Ballman, Karla V ^d   Andrade, Gabriela M ^b   Verdial, Francys C ^b   Aldrich, Melinda C ^b   Chen, Chiu L ^d   Decker, Paul A ^d   Harpole, David H ^e   Cerfolio, Robert J ^f   Keenan, Robert J ^g   Jones, David R ^h   D'Amico, Thomas A ^e   Shrager, Joseph B ⁱ   Meyers, Bryan F ^j   Putnam, Joe B ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d MAYO CLINIC   (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f University of Alabama at Birmingham   (United States)

^g ALLEGHENY GENERAL HOSPITAL   (United States)

^h MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

ⁱ STANFORD UNIVERSITY   (United States)

^j WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CARCINOMA IN SITU; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; LUNG ADENOCARCINOMA; LUNG FIBROSIS; LUNG GRANULOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LUNG TUMOR; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MELANOMA; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIODIAGNOSIS; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS;

EID: 84898602216     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2013.12.043     Document Type: Article

References (18)

1. National Comprehensive Cancer Network Lung cancer screening v1. 2012. NCCN clinical practice guidelines in oncology (NCCN Guidelines) 2011 National Comprehensive Cancer Network Ft Washington, PA
2. National Lung Screening Trial Research Team D.R. Aberle, and A.M. Adams et al. Reduced lung-cancer mortality with low-dose computed tomographic screening N Engl J Med 365 2011 395 409
3. American Lung Association. Providing guidance on lung cancer screening to patients and physicians; 2012. Available from: http://www.lung.org/lung- disease/lung-cancer/lung-cancer-screening-guidelines/. Accessed Aug 2, 2012.
4. P.B. Bach, J.N. Mirkin, and T.K. Oliver et al. Benefits and harms of CT screening for lung cancer: a systematic review JAMA 307 2012 2418 2429
5. H. Tomita, T. Kita, K. Hayashi, and S. Kosuda Radiation-induced myositis mimicking chest wall tumor invasion in two patients with lung cancer: a PET/CT study Clin Nucl Med 37 2012 168 169
6. L.L. Humphrey, M. Deffebach, and M. Pappas et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the U.S. Preventive Services Task Force recommendation Ann Intern Med 159 2013 411 420
7. S.J. Swensen, J.R. Jett, and T.E. Hartman et al. Lung cancer screening with CT: Mayo Clinic experience Radiology 226 2003 756 761
8. S.J. Swensen, J.R. Jett, and T.E. Hartman et al. CT screening for lung cancer: five-year prospective experience Radiology 235 2005 259 265
9. M.M. Wahidi, J.A. Govert, R.K. Goudar, M.K. Gould, and D.C. McCrory Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition) Chest 132 3 Suppl 2007 94 107S
10. M.K. Gould, C.C. Maclean, W.G. Kuschner, C.E. Rydzak, and D.K. Owens Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis JAMA 285 2001 914 924
11. S. Deppen, J.B. Putnam Jr., and G. Andrade et al. Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease Ann Thorac Surg 92 2011 428 432 discussion 433
12. D.R. Croft, J. Trapp, and K. Kernstine et al. FDG-PET imaging and the diagnosis of non-small cell lung cancer in a region of high histoplasmosis prevalence Lung Cancer 36 2002 297 301
13. D. Harpole, K.V. Ballman, and A.L. Oberg et al. Proteomic analysis for detection of NSCLC: results of ACOSOG z4031 J Clin Oncol 29 2011 Suppl:abstr 7003
14. D. Delbeke, R.E. Coleman, and M.J. Guiberteau et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0 J Nucl Med 47 2006 885 895
15. G.A. Silvestri, M.K. Gould, and M.L. Margolis et al. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition) Chest 132 3 Suppl 2007 178 201S
16. P. Cronin, B. Dwamena, A. Kelly, and R. Carlos Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy Radiology 246 2008 772 782
17. L. Edwards, F. Acquaviva, V. Livesay, F. Cross, and C. Palmer An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the united states Am Rev Respir Dis 99 Suppl 1969 1 132
18. M.S. Lauer, S.C. Murthy, E.H. Blackstone, I.C. Okereke, and T.W. Rice [18f]Fluorodeoxyglucose uptake by positron emission tomography for diagnosis of suspected lung cancer: Impact of verification bias Arch Intern Med 167 2007 161 165